TrialJournal of Crohn's & colitis2021
Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study.
William J Sandborn et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
62 papers cite itlatest 60 shown
this paperpooled ittrialcites it